Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BridgeBio Pharma (BBIO) FCF Payout Ratio (2019)

BridgeBio Pharma (BBIO) has disclosed FCF Payout Ratio for 1 consecutive years, with 1.07 as the latest value for Q3 2019.

  • Quarterly FCF Payout Ratio changed N/A to 1.07 in Q3 2019 from the year-ago period, while the trailing twelve-month figure was 0.21 through Dec 2019, changed N/A year-over-year, with the annual reading at 0.01 for FY2020, 94.28% up from the prior year.
  • FCF Payout Ratio hit 1.07 in Q3 2019 for BridgeBio Pharma, down from 0.02 in the prior quarter.
  • In the past five years, FCF Payout Ratio ranged from a high of 0.02 in Q1 2019 to a low of 1.07 in Q3 2019.